SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-14-133782
Filing Date
2014-04-07
Accepted
2014-04-07 17:19:40
Documents
10
Period of Report
2014-05-16
Effectiveness Date
2014-04-07

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT d628649ddef14a.htm DEF 14A 980029
2 GRAPHIC g628649g05e59.jpg GRAPHIC 11311
3 GRAPHIC g628649g20s51.jpg GRAPHIC 11399
4 GRAPHIC g628649g86b38.jpg GRAPHIC 6075
5 GRAPHIC g628649pc_pg01anew.jpg GRAPHIC 37849
6 GRAPHIC g628649pc_pg01b.jpg GRAPHIC 44974
7 GRAPHIC g628649pc_pg01c.jpg GRAPHIC 3992
8 GRAPHIC g628649pc_pg01d.jpg GRAPHIC 15253
9 GRAPHIC g628649pc_pg01f.jpg GRAPHIC 32172
10 GRAPHIC g628649pc_pg02a.jpg GRAPHIC 6379
  Complete submission text file 0001193125-14-133782.txt   1215871
Mailing Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021
Business Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021 4255274000
SEATTLE GENETICS INC /WA (Filer) CIK: 0001060736 (see all company filings)

IRS No.: 911874389 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-32405 | Film No.: 14749411
SIC: 2836 Biological Products, (No Diagnostic Substances)